These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1206 related items for PubMed ID: 19528804

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cytoreductive nephrectomy in metastatic renal cell carcinoma.
    Margulis V, Matin SF, Wood CG.
    Curr Opin Urol; 2008 Sep; 18(5):474-80. PubMed ID: 18670270
    [Abstract] [Full Text] [Related]

  • 3. Cytoreductive nephrectomy for metastatic renal cell carcinoma: is it still imperative in the era of targeted therapy?
    Pantuck AJ, Belldegrun AS, Figlin RA.
    Clin Cancer Res; 2007 Jan 15; 13(2 Pt 2):693s-696s. PubMed ID: 17255295
    [Abstract] [Full Text] [Related]

  • 4. The role of cytoreductive nephrectomy in the era of molecular targeted therapy.
    Polcari AJ, Gorbonos A, Milner JE, Flanigan RC.
    Int J Urol; 2009 Mar 15; 16(3):227-33. PubMed ID: 19207114
    [Abstract] [Full Text] [Related]

  • 5. Presurgical therapy in metastatic renal cell carcinoma.
    Jonasch E.
    Expert Rev Anticancer Ther; 2007 Jan 15; 7(1):73-8. PubMed ID: 17187521
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Role of surgery (cytoreductive nephrectomy and metastasectomy) in the management of metastatic renal cell carcinoma: a literature review].
    Arroua F, Maurin C, Carcenac A, Ragni E, Rossi D, Bastide C.
    Prog Urol; 2010 Dec 15; 20(13):1175-83. PubMed ID: 21130395
    [Abstract] [Full Text] [Related]

  • 8. Neoadjuvant (presurgical) therapy for renal cell carcinoma: a new treatment paradigm for locally advanced and metastatic disease.
    Wood CG, Margulis V.
    Cancer; 2009 May 15; 115(10 Suppl):2355-60. PubMed ID: 19402066
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: combining surgery and systemic therapies to improve patient outcome.
    Wood CG.
    Clin Cancer Res; 2007 Jan 15; 13(2 Pt 2):697s-702s. PubMed ID: 17255296
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Current status of cytoreductive nephrectomy in metastatic renal cell carcinoma.
    Harshman LC, Srinivas S.
    Expert Rev Anticancer Ther; 2007 Dec 15; 7(12):1749-61. PubMed ID: 18062749
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Selecting patients for cytoreductive nephrectomy in advanced renal cell carcinoma: who and when.
    Bex A, Powles T.
    Expert Rev Anticancer Ther; 2012 Jun 15; 12(6):787-97. PubMed ID: 22716495
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma.
    Krambeck AE, Leibovich BC, Lohse CM, Kwon ED, Zincke H, Blute ML.
    J Urol; 2006 Nov 15; 176(5):1990-5; discussion 1995. PubMed ID: 17070231
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.